Belmont Global Advisors’s Fibrocell Science Inc. FCSC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q3
Sell
-6,443
Closed -$509K 93
2015
Q2
$509K Sell
6,443
-922
-13% -$62.1K 0.56% 56
2015
Q1
$498K Buy
+7,365
New +$474K 0.51% 53
2014
Q4
Sell
-1,000
Closed -$43K 145
2014
Q3
$43K Sell
1,000
-16,667
-94% -$780K 0.03% 121
2014
Q2
$1.06M Sell
17,667
-13,646
-44% -$761K 0.76% 40
2014
Q1
$2.46M Buy
31,313
+14,646
+88% +$1.14M 2.07% 8
2013
Q4
$1.01M Buy
+16,667
New +$970K 0.82% 34

Other funds holding FCSC

Belmont Global Advisors's FCSC Position: Q3 2015 in Review

Belmont Global Advisors sold out of Fibrocell Science Inc. (FCSC) in Q3 2015, closing a stake of 6,443 shares — an estimated $509K sold.

Belmont Global Advisors first reported a position in FCSC in Q4 2013 and held it in 6 quarters. The position peaked at $2.46M in Q1 2014. 53 funds tracked by Wall St. Rank hold FCSC as of Q3 2015.

  • Belmont Global Advisors reported no remaining Fibrocell Science Inc. position as of Q3 2015 after selling out during the quarter.
  • Belmont Global Advisors sold 6,443 Fibrocell Science Inc. shares in Q3 2015, an estimated $509K.
  • Belmont Global Advisors first reported a position in Fibrocell Science Inc. in Q4 2013 and held it in 6 quarters.
  • Belmont Global Advisors's Fibrocell Science Inc. position peaked at $2.46M in Q1 2014.
  • 53 funds tracked by Wall St. Rank held Fibrocell Science Inc. as of Q3 2015.

Based on Belmont Global Advisors's 13F filing for Q3 2015, filed 16 Nov 2015.